Cleared Traditional

K192907 - Advocate PTA Catheter

K192907 is the FDA 510(k) clearance for Advocate PTA Catheter by Merit Medical Systems, Inc.. It is a Class 2 Cardiovascular device (product code LIT) cleared through the Traditional 510(k) pathway after a 42-day FDA review.

K192907 · Merit Medical Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2019
Decision
42d
Days
Class 2
Risk

K192907 is an FDA 510(k) clearance for the Advocate PTA Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Merit Medical Systems, Inc. (Galway, IE). The FDA issued a Cleared decision on November 26, 2019 after a review of 42 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Merit Medical Systems, Inc. devices

Submission Details

510(k) Number K192907 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 2019
Decision Date November 26, 2019
Days to Decision 42 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 125d · This submission: 42d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 238
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K192907.
Infinity Angioplasty Balloon Catheter
K192399 · Infinity Angioplasty Balloon Company, LLC · May 2020
Surmodics Sublime Radial Access 014 RX PTA (Percutaneous Transluminal Angioplasty) Dilatation Catheter
K200700 · Creagh Medical, Ltd. · May 2020
All’InCath 035M PTA Balloon Dilatation Catheter
K191275 · Nexstep Medical · Jan 2020
Cronus HP PTA Balloon Catheter
K190037 · Nipro Medical Corporation · Oct 2019
Ultraverse 014 and 018 PTA Balloon Dilatation Catheters
K192318 · Bard Peripheral Vascular, Inc. · Oct 2019
EverCrossTM 0.035 OTW PTA Dilatation Catheter
K190753 · Medtronic, Inc. (Formerly D.B.A. Ev3, Inc. Covidien, LLC.) · Apr 2019